{"id":68799,"date":"2013-09-12T10:19:27","date_gmt":"2013-09-12T09:19:27","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=2949"},"modified":"2013-09-12T10:19:27","modified_gmt":"2013-09-12T09:19:27","slug":"futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/","title":{"rendered":"Futur de la formulaci\u00f3 magistral: comunicaci\u00f3 amb el metge i tractaments personalitzats"},"content":{"rendered":"<p>\u201cHi ha molts pacients que necessiten l\u2019adequaci\u00f3 dels tractaments i la formulaci\u00f3 magistral n\u2019\u00e9s una resposta: aquesta \u00e9s una de les raons per les quals t\u00e9 una excel\u00b7lent perspectiva en els propers anys\u201d. S\u00f3n paraules de <b>Francesc Llamb\u00ed<\/b>, president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona, qui ha <b>apuntat les claus perqu\u00e8 la formulaci\u00f3 magistral sigui una eina de futur<\/b>. Ho ha fet en el marc del Congr\u00e9s 2013 de la FIP (International Pharmaceutical Federation), celebrat a Dubl\u00edn del 31 d\u2019agost al 5 de setembre.<\/p>\n<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/09\/francesc-llambi.jpg\"><img decoding=\"async\" class=\" wp-image-2953  alignright\" title=\"Francesc Llamb\u00ed\" alt=\"francesc-llambi\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2013\/09\/francesc-llambi-200x300.jpg\" width=\"108\" height=\"162\" \/><\/a><\/p>\n<p>[tabs type=&#8221;horizontal&#8221;][tab_title][\/tab_title][tab]Una de les conclusions aportades per Llamb\u00ed \u00e9s que \u201cLa formulaci\u00f3 magistral trobar\u00e0 el seu lloc en el futur si sabem com trobar aplicacions minorit\u00e0ries per a principis actius ja registrats, establir una bona comunicaci\u00f3 amb els metges per a una millor prescripci\u00f3 de tractaments personalitzats i detectar \u00e0rees amb un volum important de poblaci\u00f3 que necessiti l\u2019adequaci\u00f3 dels tractaments a necessitats especials no cobertes per les presentacions comercialitzades\u201d[\/tab][\/tabs]<\/p>\n<p>Durant la seva pon\u00e8ncia, inclosa a la sessi\u00f3 de formulaci\u00f3 magistral del Congr\u00e9s \u2013<i>The role of compounding in closing therapeutic gaps<\/i>-, Llamb\u00ed va aportar casos i refer\u00e8ncies cient\u00edfiques recents que avalen l\u2019important paper de la formulaci\u00f3 magistral en els darrers quinze anys, amb la incorporaci\u00f3 d\u2019un important nombre de principis actius (tacrolim\u00fas \u2013immunodepressor-, tazarot\u00e8 \u2013antiacn\u00e8ic, antipsori\u00e0sic-, prednicarbat \u2013glucocorticoide-, calcipotriol \u2013antipsori\u00e0sic-, etc.), vehicles (dermocosm\u00e8tics, olis, laques, escumes, lollipops, etc.) i els seus extraordinaris resultats com a eina per a la personalitzaci\u00f3 dels tractaments.<\/p>\n<p>Els arguments aportats per l\u2019expert van demostrar que la formulaci\u00f3 magistral compleix totes i cada una de les <b>set utilitats<\/b> encomanades a la formulaci\u00f3 magistral actualment:<\/p>\n<p><strong><span style=\"color: #888888;\">1.<\/span><\/strong> cobrir buits terap\u00e8utics;<\/p>\n<p><strong><span style=\"color: #888888;\">2.<\/span><\/strong> donar resposta terap\u00e8utica en el cas de medicacions que han deixat de comercialitzar-se per\u00f2 que continuen sent la primera opci\u00f3 de tractament, per exemple en casos com la dermatitis herpetiforme i la queratosis act\u00ednica;<\/p>\n<p><strong><span style=\"color: #888888;\">3.<\/span><\/strong> facilitar l\u2019administraci\u00f3 del medicament, ja sigui en el tractament de patologies que coexisteixen (ros\u00e0cia i dermatitis seborreica, o acne i melasma) o b\u00e9 en l\u2019optimitzaci\u00f3 de les quantitats especialment en el tractament d\u2019\u00e0rees extenses;<\/p>\n<p><strong><span style=\"color: #888888;\">4.<\/span> <\/strong>ajudar en els casos d\u2019al\u00b7l\u00e8rgies i intoler\u00e0ncies;<\/p>\n<p><strong><span style=\"color: #888888;\">5.<\/span><\/strong> la individualitzaci\u00f3 dels tractaments, tant a trav\u00e9s de l\u2019ajust de les dosis com del canvi de vehicle o la combinaci\u00f3 de diferents principis actius quan \u00e9s convenient;<\/p>\n<p><strong><span style=\"color: #888888;\">6.<\/span><\/strong> la reducci\u00f3 de reaccions adverses;<\/p>\n<p><strong><span style=\"color: #888888;\">7.<\/span> <\/strong>complir amb altres requeriments en pacients hospitalitzats.<\/p>\n<p>&nbsp;<\/p>\n<p>El president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona va compartir sessi\u00f3 amb experts de tot el m\u00f3n, que van posar l\u2019\u00e8mfasi en diferents aspectes de la formulaci\u00f3 magistral, des de normatives o est\u00e0ndards de qualitat, fins a les seves aplicacions en altres \u00e0rees com la pedi\u00e0trica o les precaucions de farmac\u00e8utics de tot el m\u00f3n a l\u2019hora de formular.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u201cHi ha molts pacients que necessiten l\u2019adequaci\u00f3 dels tractaments i la formulaci\u00f3 magistral n\u2019\u00e9s una resposta: aquesta \u00e9s una de les raons per les quals t\u00e9 una excel\u00b7lent perspectiva en els propers anys\u201d. S\u00f3n paraules de Francesc Llamb\u00ed, president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona, qui ha [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2993,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[32],"tags":[650],"class_list":["post-68799","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticies-farmacia","tag-formulacio-magistral"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Futur de la formulaci\u00f3 magistral: comunicaci\u00f3 amb el metge i tractaments personalitzats - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Futur de la formulaci\u00f3 magistral: comunicaci\u00f3 amb el metge i tractaments personalitzats - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u201cHi ha molts pacients que necessiten l\u2019adequaci\u00f3 dels tractaments i la formulaci\u00f3 magistral n\u2019\u00e9s una resposta: aquesta \u00e9s una de les raons per les quals t\u00e9 una excel\u00b7lent perspectiva en els propers anys\u201d. S\u00f3n paraules de Francesc Llamb\u00ed, president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona, qui ha [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-09-12T09:19:27+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Futur de la formulaci\u00f3 magistral: comunicaci\u00f3 amb el metge i tractaments personalitzats\",\"datePublished\":\"2013-09-12T09:19:27+00:00\",\"dateModified\":\"2013-09-12T09:19:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/\"},\"wordCount\":510,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Formulaci\u00f3 magistral\"],\"articleSection\":[\"Not\u00edcies farm\u00e0cia\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/\",\"name\":\"Futur de la formulaci\u00f3 magistral: comunicaci\u00f3 amb el metge i tractaments personalitzats - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2013-09-12T09:19:27+00:00\",\"dateModified\":\"2013-09-12T09:19:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Futur de la formulaci\u00f3 magistral: comunicaci\u00f3 amb el metge i tractaments personalitzats\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Futur de la formulaci\u00f3 magistral: comunicaci\u00f3 amb el metge i tractaments personalitzats - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/","og_locale":"ca_ES","og_type":"article","og_title":"Futur de la formulaci\u00f3 magistral: comunicaci\u00f3 amb el metge i tractaments personalitzats - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u201cHi ha molts pacients que necessiten l\u2019adequaci\u00f3 dels tractaments i la formulaci\u00f3 magistral n\u2019\u00e9s una resposta: aquesta \u00e9s una de les raons per les quals t\u00e9 una excel\u00b7lent perspectiva en els propers anys\u201d. S\u00f3n paraules de Francesc Llamb\u00ed, president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona, qui ha [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2013-09-12T09:19:27+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Futur de la formulaci\u00f3 magistral: comunicaci\u00f3 amb el metge i tractaments personalitzats","datePublished":"2013-09-12T09:19:27+00:00","dateModified":"2013-09-12T09:19:27+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/"},"wordCount":510,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#primaryimage"},"thumbnailUrl":"","keywords":["Formulaci\u00f3 magistral"],"articleSection":["Not\u00edcies farm\u00e0cia"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/","url":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/","name":"Futur de la formulaci\u00f3 magistral: comunicaci\u00f3 amb el metge i tractaments personalitzats - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#primaryimage"},"thumbnailUrl":"","datePublished":"2013-09-12T09:19:27+00:00","dateModified":"2013-09-12T09:19:27+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2013\/09\/12\/futur-de-la-formulacio-magistral-comunicacio-amb-el-metge-i-tractaments-personalitzats\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Futur de la formulaci\u00f3 magistral: comunicaci\u00f3 amb el metge i tractaments personalitzats"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u201cHi ha molts pacients que necessiten l\u2019adequaci\u00f3 dels tractaments i la formulaci\u00f3 magistral n\u2019\u00e9s una resposta: aquesta \u00e9s una de les raons per les quals t\u00e9 una excel\u00b7lent perspectiva en els propers anys\u201d. S\u00f3n paraules de Francesc Llamb\u00ed, president d\u2019Aprofarm i vocal del Col\u00b7legi de Farmac\u00e8utics de Barcelona, qui ha [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/68799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=68799"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/68799\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=68799"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=68799"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=68799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}